Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 09, 2025 08:30 ET | Source: SNS Insider pvt ltd

Omics-Based Clinical Trials Market to Surpass USD 61.98 Billion by 2032 Driven by Precision Medicine and Multi-Omics Integration – SNS Insider

Austin, Texas, Dec. 09, 2025 (GLOBE NEWSWIRE) -- According to SNS Insider, The Omics-based Clinical Trials Market size was valued at USD 32.75 billion in 2024 and is expected to reach USD 61.98...
December 02, 2025 08:00 ET | Source: Silexion Therapeutics Corp

Silexion Therapeutics Receives Positive Feedback from German Health Authority on Design of Phase 2/3 Clinical Trial in Pancreatic Cancer

Positive feedback reinforces Silexion’s trajectory toward its planned Phase 2/3 trial initiation in Q2 2026 Company plans to complete regulatory submissions to the Israeli Ministry of Health by the...
November 26, 2025 07:30 ET | Source: Research and Markets

Genomics Collaboration and Licensing Agreements Trends Analysis Report 2025 with Directory of 639 Deals Signed Since 2018 by Company A-Z, Therapy Focus and Technology Type

Dublin, Nov. 26, 2025 (GLOBE NEWSWIRE) -- The "Genomic Collaboration and Licensing Deals 2018-2025" has been added to ResearchAndMarkets.com's offering.The report contains a comprehensive listing...
November 26, 2025 07:30 ET | Source: Silexion Therapeutics Corp

Silexion Therapeutics to Present at Noble Capital Markets' 21st Annual Emerging Growth Equity Conference

Grand Cayman, Cayman Islands, Nov. 26, 2025 (GLOBE NEWSWIRE) -- Silexion Therapeutics Corp. (“Silexion” or the “Company”), a clinical-stage, oncology-focused biotechnology company, today announced...
November 25, 2025 09:25 ET | Source: Research and Markets

Precision Medicine Strategic Intelligence Report 2025: Opportunities in Integrating AI and Bioinformatics to Predict Disease Risks, Enhance Diagnostics, and Shape Personalized Care

Dublin, Nov. 25, 2025 (GLOBE NEWSWIRE) -- The "Strategic Intelligence: Precision Medicine (2025)" report has been added to ResearchAndMarkets.com's offering.Precision medicine is revolutionizing...
November 25, 2025 09:15 ET | Source: Silexion Therapeutics Corp

Silexion Therapeutics Successfully Completes Toxicology Studies for SIL204, Next-Generation RNA Silencing Therapy, Ahead of Phase 2/3 Clinical Trial in Pancreatic Cancer

Successful completion of two-species toxicology studies confirms no systemic organ toxicity, advancing the Company towards its planned regulatory submissions to Israel and Germany Company remains on...
November 19, 2025 04:24 ET | Source: Research and Markets

$32.88 Bn In-vitro Toxicology Testing Market Trends and Forecasts, 2020-2024 & 2025-2030: Rising Personalized Medicine Applications, and Rising Demand For Safety Assessment Of New Drugs And Chemicals

Dublin, Nov. 19, 2025 (GLOBE NEWSWIRE) -- The "In-vitro Toxicology Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" report has been added to ...
November 14, 2025 08:00 ET | Source: Paragon Genomics

Paragon Genomics Introduces New CleanPlex® NGS Panel for Pharmacogenomics Profiling at AMP 2025

Paragon Genomics has launched its CleanPlex® Pharmacogenomics NGS Panel that delivers a comprehensive, efficient, cost-effective pharmacogenomics solution.
November 12, 2025 09:00 ET | Source: Silexion Therapeutics Corp

Silexion Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update

Continued advancement toward Phase 2/3 clinical trial initiation, on track for the first half of 2026 New preclinical data demonstrated SIL204’s exceptional efficacy across multiple human cancer cell...
November 12, 2025 05:09 ET | Source: Research and Markets

RNA Targeting Small Molecules Therapeutics Global Research Report 2025: 7.03 Billion Market Opportunities and Strategies to 2034 - Expansion in AI-driven Drug Discovery, Alliances, Emerging Markets

Dublin, Nov. 12, 2025 (GLOBE NEWSWIRE) -- The "RNA Targeting Small Molecules Therapeutics Global Market Opportunities And Strategies To 2034" report has been added to ResearchAndMarkets.com's...